中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (2E,4E,6S,7S,8R,9S,10E)-7,9-dimethoxy-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienoic acid | 443123-81-7 | C22H30O4 | 358.478 |
—— | (2E,4E,6S,7S,8R,9S,10E)-methyl 7,9-dimethoxy-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienoate | 405150-67-6 | C23H32O4 | 372.505 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 2-trimethylsilylethyl N-[(2E,4E,6S,7S,8R,9S,10E)-7,9-dimethoxy-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienoyl]-N-[(Z)-6-hydroxyhex-1-enyl]carbamate | 405150-71-2 | C34H53NO6Si | 599.883 |
—— | (2Z,5Z)-6-[((2E,4E,10E)-(6S,7S,8R,9S)-7,9-Dimethoxy-3,6,8-trimethyl-11-phenyl-undeca-2,4,10-trienoyl)-(2-trimethylsilanyl-ethoxycarbonyl)-amino]-hexa-2,5-dienoic acid | 633302-57-5 | C34H49NO7Si | 611.851 |
—— | 2-trimethylsilylethyl N-[(1Z,4Z)-6-[tert-butyl(dimethyl)silyl]oxyhexa-1,4-dienyl]-N-[(2E,4E,6S,7S,8R,9S,10E)-7,9-dimethoxy-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienoyl]carbamate | 633302-55-3 | C40H65NO6Si2 | 712.13 |
—— | 2-trimethylsilylethyl N-[(Z)-6-[tert-butyl(dimethyl)silyl]oxyhex-1-enyl]-N-[(2E,4E,6S,7S,8R,9S,10E)-7,9-dimethoxy-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienoyl]carbamate | 405150-70-1 | C40H67NO6Si2 | 714.146 |
—— | methyl 2-[[(Z)-6-[[(2E,4E,6S,7S,8R,9S,10E)-7,9-dimethoxy-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienoyl]-(2-trimethylsilylethoxycarbonyl)amino]hex-5-enoyl]amino]acetate | 405150-72-3 | C37H56N2O8Si | 684.946 |
The first asymmetric total synthesis of the electron-transport inhibitor crocacin A (1) is described. The key step involved acylation of the anion derived from dienecarbamate (6) with the acid chloride (5) to afford the enamide (14). Desilylation, oxidation, and N-deprotection gave acid (17), which was coupled with glycine methyl ester to afford (1).